COV Share Price Performance
AU$0.63
0.29 (85.29%)
Price AU$0.63
Share Pricen/a
Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth
Sep 10
Cleo Diagnostics Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
COV Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Cleo Diagnostics Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.031
- 100.00%
- -473.17%
- 0%
About COV
- Founded
- 2021
- Employees
- n/a
- CEO
- WebsiteView website
Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
